These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17652710)

  • 1. Paclitaxel in the treatment of retinal tumors of LH beta-Tag murine transgenic model of retinoblastoma.
    Suárez F; Jockovich ME; Hernandez E; Feuer W; Parel JM; Murray TG
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3437-40. PubMed ID: 17652710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.
    Van Quill KR; Dioguardi PK; Tong CT; Gilbert JA; Aaberg TM; Grossniklaus HE; Edelhauser HF; O'Brien JM
    Ophthalmology; 2005 Jun; 112(6):1151-8. PubMed ID: 15885791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma.
    Tsui JY; Dalgard C; Van Quill KR; Lee L; Grossniklaus HE; Edelhauser HF; O'Brien JM
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):490-6. PubMed ID: 18234990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity and dose-response studies of 1-alpha hydroxyvitamin D2 in LH-beta-tag transgenic mice.
    Dawson DG; Gleiser J; Zimbric ML; Darjatmoko SR; Lindstrom MJ; Strugnell SA; Albert DM
    Ophthalmology; 2003 Apr; 110(4):835-9. PubMed ID: 12689912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combretastatin A-4 prodrug in the treatment of a murine model of retinoblastoma.
    Escalona-Benz E; Jockovich ME; Murray TG; Hayden B; Hernandez E; Feuer W; Windle JJ
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):8-11. PubMed ID: 15623747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iontophoretic delivery of carboplatin in a murine model of retinoblastoma.
    Hayden B; Jockovich ME; Murray TG; Kralinger MT; Voigt M; Hernandez E; Feuer W; Parel JM
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3717-21. PubMed ID: 16936078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anecortave acetate as single and adjuvant therapy in the treatment of retinal tumors of LH(BETA)T(AG) mice.
    Jockovich ME; Murray TG; Escalona-Benz E; Hernandez E; Feuer W
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1264-8. PubMed ID: 16565356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma.
    Abramson DH; Frank CM; Dunkel IJ
    Ophthalmology; 1999 Oct; 106(10):1947-50. PubMed ID: 10519590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local carboplatin therapy in transgenic murine retinoblastoma.
    Harbour JW; Murray TG; Hamasaki D; Cicciarelli N; Hernández E; Smith B; Windle J; O'Brien JM
    Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1892-8. PubMed ID: 8759359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subconjunctival carboplatin in retinoblastoma: impact of tumor burden and dose schedule.
    Hayden BH; Murray TG; Scott IU; Cicciarelli N; Hernandez E; Feuer W; Fulton L; O'Brien JM
    Arch Ophthalmol; 2000 Nov; 118(11):1549-54. PubMed ID: 11074812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External beam radiation "salvage" therapy in transgenic murine retinoblastoma.
    Sobrin L; Hayden BC; Murray TG; Cicciarelli N; Scott IU; Hernandez E; Wu X; Markoe AM; Feuer W; Fulton L; O'Brien JM
    Arch Ophthalmol; 2004 Feb; 122(2):251-7. PubMed ID: 14769602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subconjunctival nanoparticle carboplatin in the treatment of murine retinoblastoma.
    Kang SJ; Durairaj C; Kompella UB; O'Brien JM; Grossniklaus HE
    Arch Ophthalmol; 2009 Aug; 127(8):1043-7. PubMed ID: 19667343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting hypoxia, a novel treatment for advanced retinoblastoma.
    Boutrid H; Jockovich ME; Murray TG; Piña Y; Feuer WJ; Lampidis TJ; Cebulla CM
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2799-805. PubMed ID: 18326690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma.
    Murray TG; Cicciarelli N; O'Brien JM; Hernández E; Mueller RL; Smith BJ; Feuer W
    Arch Ophthalmol; 1997 Oct; 115(10):1286-90. PubMed ID: 9338675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The experiment research of subconjunctival injections with etoposide for the treatment of retinoblastoma mice.
    Mao Y; Zhongyao W; Huasheng Y; Zheng J; He J; Li W
    Yan Ke Xue Bao; 2005 Sep; 21(3):169-74. PubMed ID: 17162856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity and dose-response studies of 1 alpha-hydroxyvitamin D2 in LH beta-Tag transgenic mice.
    Dawson DG; Gleiser J; Zimbric ML; Darjatmoko SR; Frisbie JC; Lokken JM; Lindstrom MJ; Audo I; Strugnell SA; Albert DM
    Trans Am Ophthalmol Soc; 2002; 100():125-9. PubMed ID: 12545685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model.
    Jockovich ME; Suarez F; Alegret A; Piña Y; Hayden B; Cebulla C; Feuer W; Murray TG
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5371-6. PubMed ID: 18055783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topotecan combination chemotherapy in two new rodent models of retinoblastoma.
    Laurie NA; Gray JK; Zhang J; Leggas M; Relling M; Egorin M; Stewart C; Dyer MA
    Clin Cancer Res; 2005 Oct; 11(20):7569-78. PubMed ID: 16243833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of vitamin D analogues in treating large tumors and during prolonged use in murine retinoblastoma models.
    Albert DM; Kumar A; Strugnell SA; Darjatmoko SR; Lokken JM; Lindstrom MJ; Patel S
    Arch Ophthalmol; 2004 Sep; 122(9):1357-62. PubMed ID: 15364716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma.
    Dalgard CL; Van Quill KR; O'Brien JM
    Clin Cancer Res; 2008 May; 14(10):3113-23. PubMed ID: 18483379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.